IBUPROFENE ZENTIVA CONSEIL 400 mg, film-coated tablet 15 tablets
Active ingredients: Ibuprofen
Commercialized according to BDPM
Film-coated tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IBUPROFENE ZENTIVA CONSEIL 400 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62525923CIP73024871CIP133400930248713Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IBUPROFÈNEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.